Non-lytic antibodies in H-2-controlled resistance to acute infection with Trypanosoma cruzi

M A Juri1, A Ferreira, A Ramos

  • 1Departamento de Biología Celular y Genética, Facultad de Medicina, Universidad de Chile, Santiago.

1. Resistance to acute Trypanosoma cruzi infection in mice is a polygenic character with a major factor linked to the murine major histocompatibility system (H-2). We found that F1 hybrids A.CA(H-2f)/B10.Br(H-2k) between two susceptible strains are strongly resistant. 2. Resistant B10(H-2b) and A.SW(H-2s) animals survived 60 or more days after an intraperitoneal injection of 10(4) Tulahuén strain blood trypomastigotes. The specific antibody response of these individuals increased continuously up to 100 days or more. Parasitemia reached a peak at day 8 in all strains. Thereafter, the number of blood parasites in resistant animals showed an irregular but persistent decrease. 3. Susceptible congenic B10.Br and A.CA animals showed lower levels of specific anti-T. cruzi antibodies and an increase in parasitemia until death. B10.Br mice died 14 to 20 days after infection. A.CA animals were extremely susceptible, showing a sharp and sustained increase in parasitemia starting on day 12, followed by death no later than day 15 post-inoculation. 4. We found a significant correlation between IgG levels present in serum of resistant mice from 20 days on and protection against acute death. Whole immune anti-T. cruzi serum or its purified IgG class fraction neutralized T. cruzi inocula in vitro as shown by a significantly increased survival of recipient susceptible A.CA mice. 5. This IgG protective effect is independent of the protective effect mediated by the terminal activation of the complement cascade, since the parasites were inoculated with heat-inactivated immune sera and both recipient (A.CA) and donor (A.SW) strains lack C5.

Related Concept Videos

Humoral Immune Responses01:36

Humoral Immune Responses

Overview
Cross-reactivity00:42

Cross-reactivity

Overview
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Leishmaniasis01:30

Leishmaniasis

Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
American Trypanosomiasis01:22

American Trypanosomiasis

Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...